Expression and Substrate Specificities of Human Thymidine Kinase 1, Thymidine Kinase 2 and Deoxycytidine Kinase

Author(s):  
Staffan Eriksson ◽  
Birgitte Munch-Petersen ◽  
Borys Kierdaszuk ◽  
Elias Arnér
2006 ◽  
Vol 71 (7) ◽  
pp. 1063-1087 ◽  
Author(s):  
Jean-François Griffon ◽  
Sue C. Shaddix ◽  
William B. Parker ◽  
Ashraf S. Al-Madhoun ◽  
Staffan Eriksson ◽  
...  

A series of 4'-C-(hydroxymethyl) analogs of pyrimidine and purine nucleosides have been prepared utilizing standard methodologies, and the α and β anomers were separated. These analogs are part of our continuing efforts to identify new anticancer drugs as well as to explore the substrate specificities of these analogs with the initial activating enzymes in the metabolic pathway leading to nucleoside triphosphates. Although not cytotoxic to CCRF-CEM cells (an acute lymphoblastic leukemia of T-cell origin), many of these compounds were utilized as substrates for the various human nucleoside kinases, including deoxycytidine kinase, thymidine kinase 1, and thymidine kinase 2. Because the 4'-C-(hydroxymethyl) analog of arabinofuranosyl cytosine was identified as a good substrate with deoxycytidine kinase, its metabolism in CEM cells was evaluated. These results indicated that nucleosides with this modification could be activated in human cells without cytotoxicity, which suggested that they should be examined for antiviral activity.


Sign in / Sign up

Export Citation Format

Share Document